Perdas E - Search Results

1

High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation.

Mikulski D, Nowicki M, Dróźdż I, Misiewicz M, Kościelny KP, Okoński K, Krawiec K, Perdas E, Wierzbowska A, Fendler W. Mikulski D, et al. Among authors: perdas e. Front Oncol. 2023 Sep 27;13:1250355. doi: 10.3389/fonc.2023.1250355. eCollection 2023. Front Oncol. 2023. PMID: 37829335 Free PMC article.

2

Pretreatment Serum Levels of IL-1 Receptor Antagonist and IL-4 Are Predictors of Overall Survival in Multiple Myeloma Patients Treated with Bortezomib.

Mikulski D, Robak P, Perdas E, Węgłowska E, Łosiewicz A, Dróżdż I, Jarych D, Misiewicz M, Szemraj J, Fendler W, Robak T. Mikulski D, et al. Among authors: perdas e. J Clin Med. 2021 Dec 26;11(1):112. doi: 10.3390/jcm11010112. J Clin Med. 2021. PMID: 35011853 Free PMC article.

3

Case report: Neonatal diabetes mellitus with congenital hypothyroidism as a result of biallelic heterozygous mutations in GLIS3 gene.

Perdas E, Gadzalska K, Hrytsiuk I, Borowiec M, Fendler W, Młynarski W. Perdas E, et al. Pediatr Diabetes. 2022 Sep;23(6):668-674. doi: 10.1111/pedi.13341. Epub 2022 Apr 24. Pediatr Diabetes. 2022. PMID: 35394098

4

Current Trends in Cell-Free DNA Applications. Scoping Review of Clinical Trials.

Stawski R, Stec-Martyna E, Chmielecki A, Nowak D, Perdas E. Stawski R, et al. Among authors: perdas e. Biology (Basel). 2021 Sep 13;10(9):906. doi: 10.3390/biology10090906. Biology (Basel). 2021. PMID: 34571783 Free PMC article. Review.

5

Cell-Free DNA: Potential Application in COVID-19 Diagnostics and Management.

Stawski R, Nowak D, Perdas E. Stawski R, et al. Among authors: perdas e. Viruses. 2022 Feb 4;14(2):321. doi: 10.3390/v14020321. Viruses. 2022. PMID: 35215914 Free PMC article. Review.

6

Changes in the cardiovascular system in children with pediatric multisystem inflammatory syndrome temporally associated with COVID-19 - A single center experience.

Stasiak A, Kędziora P, Kierzkowska B, Niewiadomska-Jarosik K, Perdas E, Smolewska E. Stasiak A, et al. Among authors: perdas e. Int J Cardiol. 2022 Aug 15;361:126-133. doi: 10.1016/j.ijcard.2022.05.030. Epub 2022 May 14. Int J Cardiol. 2022. PMID: 35577166 Free PMC article.

7

Potential of Liquid Biopsy in Papillary Thyroid Carcinoma in Context of miRNA, BRAF and p53 Mutation.

Perdas E, Stawski R, Nowak D, Zubrzycka M. Perdas E, et al. Curr Drug Targets. 2018;19(14):1721-1729. doi: 10.2174/1389450119666180226124349. Curr Drug Targets. 2018. PMID: 29484992 Review.

8

Analysis of Let-7 Family miRNA in Plasma as Potential Predictive Biomarkers of Diagnosis for Papillary Thyroid Cancer.

Perdas E, Stawski R, Kaczka K, Zubrzycka M. Perdas E, et al. Diagnostics (Basel). 2020 Feb 28;10(3):130. doi: 10.3390/diagnostics10030130. Diagnostics (Basel). 2020. PMID: 32121086 Free PMC article.

9

Genetic, Epigenetic, and Steroidogenic Modulation Mechanisms in Endometriosis.

Zubrzycka A, Zubrzycki M, Perdas E, Zubrzycka M. Zubrzycka A, et al. Among authors: perdas e. J Clin Med. 2020 May 2;9(5):1309. doi: 10.3390/jcm9051309. J Clin Med. 2020. PMID: 32370117 Free PMC article. Review.

10

Risk factors of a severe course of pediatric multi-system inflammatory syndrome temporally associated with COVID-19.

Stasiak A, Perdas E, Smolewska E. Stasiak A, et al. Among authors: perdas e. Eur J Pediatr. 2022 Oct;181(10):3733-3738. doi: 10.1007/s00431-022-04584-8. Epub 2022 Aug 10. Eur J Pediatr. 2022. PMID: 35948653 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters